Clinical Trials for Muscular Dystrophy
Project Description:
Duchenne muscular dystrophy (DMD) and Spinal Muscular Atrophy (SMA) are genetic diseases that primarily affect males and is currently fatal. Until very recently, there have been no targeted treatments for theses disease, which affect skeletal, pulmonary and cardiac muscle. New breakthroughs in medicine have led to the development of novel therapeutics. At this time, we are participating in 10 clinical trials for DMD and SMA. The staff are highly trained research physical therapists and an engineer to collect outcome data for these clinical trials. Measures include muscle strength, physical functioning, pulmonary function, walking ability and health related quality of life. We are hopeful that these clinical trials will result in FDA approval of medications to slow or even cure these currently fatal diseases.
Keyword(s):
Research, drug, muscle, Fatal disease, Duchenne Muscular Dystrophy
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A